| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Humacyte, Inc. (HUMA) has 14 insiders with recent SEC Form 4 filings, including 7 buys and 9 sells. HUMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 318.6K | $360.0K | - | |
| CFO | 313.1K | $353.8K | - | |
| Dir | 311.1K | $351.5K | - | |
| CEO | 311.1K | $351.5K | - | |
| Dir | 80.0K | $90.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2025 | Niklason Laura E66 | President, CEO And Director | Sell | 2,241,045 | $1.67 | $3,733,191.10 | -49.5% | -26.4% | - | |
| Aug 20, 2025 | Dougan Brady W60 | Director | Sell | 2,241,045 | $1.67 | $3,733,191.10 | -49.5% | -26.4% | - | |
| Apr 14, 2025 | Scheessele William John | Chief Commercial Officer | Buy | 6,493 | $1.54 | $9,999.22 | +41.8% | +65.8% | -56.7% | |
| Apr 10, 2025 | Parikh Shamik J | Chief Medical Officer | Buy | 7,500 | $1.55 | $11,625.00 | New | +61.8% | -58.9% | |
| Apr 10, 2025 | Sander Dale A.58 | CFO And Chief Corp. Deve. Off. | Buy | 20,000 | $1.53 | $30,600.00 | +97.1% | +61.8% | -58.9% | |
| Apr 8, 2025 | Sebelius Kathleen | Director | Buy | 50,000 | $1.32 | $66,000.00 | +121.3% | +87.8% | -43.3% | |
| Apr 8, 2025 | Green Charles Bruce | Director | Buy | 6,000 | $1.29 | $7,740.00 | +250.0% | +87.8% | -43.3% | |
| Apr 7, 2025 | Constantino Michael T. | Director | Buy | 16,000 | $1.26 | $20,160.00 | +94.4% | +71.4% | -51.8% | |
| Dec 4, 2024 | Constantino Michael T. | Director | Buy | 4,600 | $4.39 | $20,181.12 | +37.2% | -27.8% | -70.7% | |
| Nov 20, 2024 | Dougan Brady W60 | Director | Sell | 1,500,000 | $4.40 | $6,606,799.34 | -19.6% | -15.0% | -74.6% |